Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,884 | 110 | 99.7% |
| Education | $11.71 | 1 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $970.67 | 13 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $491.03 | 17 | $0 (2022) |
| Novo Nordisk Inc | $324.01 | 14 | $0 (2024) |
| GlaxoSmithKline, LLC. | $311.94 | 3 | $0 (2024) |
| Abbott Laboratories | $238.67 | 2 | $0 (2024) |
| PFIZER INC. | $195.03 | 13 | $0 (2022) |
| NESTLE HEALTHCARE NUTRITION INC. | $166.10 | 6 | $0 (2023) |
| AIMMUNE THERAPEUTICS, INC. | $153.86 | 6 | $0 (2024) |
| Medtronic, Inc. | $132.00 | 2 | $0 (2023) |
| Astellas Pharma US Inc | $115.76 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,001 | 15 | AstraZeneca Pharmaceuticals LP ($361.94) |
| 2023 | $930.62 | 19 | AstraZeneca Pharmaceuticals LP ($241.49) |
| 2022 | $833.21 | 35 | AstraZeneca Pharmaceuticals LP ($194.07) |
| 2021 | $1,131 | 42 | SANOFI-AVENTIS U.S. LLC ($309.45) |
All Payment Transactions
111 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $116.16 | General |
| Category: Diabetes Care | ||||||
| 10/17/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $114.45 | General |
| Category: Obesity | ||||||
| 10/15/2024 | AIMMUNE THERAPEUTICS, INC. | VOWST (Biological) | Food and Beverage | In-kind items and services | $5.12 | General |
| Category: GI | ||||||
| 09/17/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $135.00 | General |
| Category: Respiratory | ||||||
| 09/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $90.82 | General |
| Category: NEUROSCIENCE | ||||||
| 09/07/2024 | Dexcom, Inc. | DEXCOM G7 GSS (161) (Medical Supply) | Food and Beverage | In-kind items and services | $38.77 | General |
| Category: Endocrinology | ||||||
| 08/08/2024 | AIMMUNE THERAPEUTICS, INC. | VOWST (Biological) | Food and Beverage | In-kind items and services | $9.15 | General |
| Category: GI | ||||||
| 06/24/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $5.53 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 05/20/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $118.30 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 04/29/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $7.88 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 04/29/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $7.88 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 04/17/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $94.11 | General |
| Category: Respiratory | ||||||
| 03/14/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: RESPIRATORY | ||||||
| 02/29/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $92.51 | General |
| Category: Respiratory | ||||||
| 01/19/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $40.32 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/25/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/05/2023 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $17.71 | General |
| Category: Diabetes | ||||||
| 08/10/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $103.58 | General |
| Category: Biological | ||||||
| 07/19/2023 | NESTLE HEALTHCARE NUTRITION INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 06/27/2023 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $122.51 | General |
| Category: Diabetes Care | ||||||
| 06/08/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $90.81 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/18/2023 | NESTLE HEALTHCARE NUTRITION INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $7.31 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 04/28/2023 | NESTLE HEALTHCARE NUTRITION INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $7.02 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 04/14/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.75 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/13/2023 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $99.00 | General |
| Category: VACCINES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 398 | 520 | $75,056 | $21,240 |
| 2022 | 7 | 266 | 345 | $62,361 | $17,311 |
| 2021 | 8 | 251 | 365 | $49,879 | $16,088 |
| 2020 | 7 | 459 | 511 | $50,023 | $13,705 |
All Medicare Procedures & Services
33 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 142 | 166 | $40,321 | $12,036 | 29.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 41 | 47 | $16,058 | $4,091 | 25.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 24 | 24 | $5,393 | $1,367 | 25.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 24 | 25 | $4,289 | $1,255 | 29.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 11 | 11 | $3,289 | $1,049 | 31.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 54 | 62 | $528.00 | $496.48 | 94.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 25 | 44 | $2,384 | $340.27 | 14.3% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 17 | 18 | $954.00 | $238.84 | 25.0% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 12 | 12 | $551.00 | $194.40 | 35.3% |
| 81002 | Urinalysis, manual test | Office | 2023 | 35 | 43 | $387.00 | $146.63 | 37.9% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2023 | 13 | 68 | $901.74 | $25.38 | 2.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 119 | 148 | $36,112 | $9,318 | 25.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 35 | 46 | $15,778 | $4,682 | 29.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 21 | 21 | $4,431 | $1,475 | 33.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 12 | 12 | $3,732 | $1,281 | 34.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 13 | 36 | $1,620 | $296.48 | 18.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 39 | 50 | $400.00 | $148.02 | 37.0% |
| 81002 | Urinalysis, manual test | Office | 2022 | 27 | 32 | $288.00 | $110.11 | 38.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 114 | 150 | $34,200 | $10,963 | 32.1% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 15 | 21 | $6,678 | $2,556 | 38.3% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 17 | 17 | $3,315 | $1,085 | 32.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 14 | 15 | $2,400 | $925.67 | 38.6% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 23 | 37 | $1,665 | $315.86 | 19.0% |
| 81002 | Urinalysis, manual test | Office | 2021 | 25 | 33 | $297.00 | $114.84 | 38.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 32 | 36 | $288.00 | $105.39 | 36.6% |
About Connie Duda, CFNP
Connie Duda, CFNP is a Family healthcare provider based in Lincoln, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/22/2006. The National Provider Identifier (NPI) number assigned to this provider is 1881669760.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Connie Duda, CFNP has received a total of $3,896 in payments from pharmaceutical and medical device companies, with $1,001 received in 2024. These payments were reported across 111 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($3,884).
As a Medicare-enrolled provider, Duda has provided services to 1,374 Medicare beneficiaries, totaling 1,741 services with total Medicare billing of $68,345. Data is available for 4 years (2020–2023), covering 33 distinct procedure/service records.
Practice Information
- Specialty Family
- Location Lincoln, IL
- Active Since 02/22/2006
- Last Updated 06/19/2008
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1881669760
Products in Payments
- FARXIGA (Drug) $465.42
- ZENPEP (Drug) $305.69
- SOLIQUA 100/33 (Biological) $301.25
- BREZTRI (Drug) $277.74
- FREESTYLE LIBRE 3 (Device) $238.67
- AIRSUPRA (Drug) $227.51
- TOUJEO (Biological) $189.78
- Wegovy (Drug) $140.72
- Ozempic (Drug) $135.14
- COREVALVE EVOLUT R (Device) $132.00
- AREXVY (Drug) $125.00
- Veozah (Drug) $103.58
- SHINGRIX (Biological) $99.00
- VRAYLAR (Drug) $90.82
- Dayvigo (Drug) $89.90
- TRELEGY ELLIPTA (Drug) $87.94
- PREVNAR 20 (Biological) $85.14
- NURTEC ODT (Drug) $80.41
- TRULICITY (Drug) $68.06
- NEXLIZET (Drug) $67.32
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Lincoln
Mr. Shrenik Vyas, Fnp-C, FNP-C
Family — Payments: $7,719
Mrs. Mary Glade, Aprn, APRN
Family — Payments: $5,203
Jennifer Harrison
Family — Payments: $4,853
Alyson Ferguson, Aprn-Fnp-C, APRN-FNP-C
Family — Payments: $4,725
Lori Mallory, Aprn, APRN
Family — Payments: $3,974
Samantha Nice, Aprn, APRN
Family — Payments: $3,720